Apellis Pharmaceuticals, Inc. (APLS)
41.03
-0.03
(-0.07%)
USD |
NASDAQ |
May 13, 16:00
41.04
+0.01
(+0.02%)
After-Hours: 20:00
Apellis Pharmaceuticals Cash and Short Term Investments (Quarterly) : 406.73M for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Biogen, Inc. | 4.283B |
| Eli Lilly & Co. | 5.282B |
| Agios Pharmaceuticals, Inc. | 737.04M |
| Scholar Rock Holding Corp. | 479.94M |
| Kezar Life Sciences, Inc. | 66.23M |